3D Bioprinted retina models for drug screening
3D Bioprinted retina models for drug screening
批准号:
10916043
负责人:
Marc Ferrer
金额:
$226.91万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
3-DimensionalBlood-Retinal BarrierBruch&aposs basal membrane structureChoroidChoroidal NeovascularizationDiseaseDrug ModelingsDrug ScreeningEngineeringExtracellular MatrixGoalsHumanPathologic NeovascularizationPhotoreceptorsPreventionRecoveryRecurrenceRetinaRetinal DiseasesStructure of retinal pigment epitheliumTechniquesTherapeuticTissue ModelTissuesVascular EndotheliumVascularizationVirus DiseasesVisionZIKV infectionangiogenesisbevacizumabbioprintingclinically relevanthypoxia inducible factor 1improvedin vitro Modelinduced pluripotent stem cellnew therapeutic targettherapeutic developmenttherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
An engineered ocular tissue of outer blood retina barrier containing RPE and three dimensional (3D) vascularized tissue has been produced using bioprinting techniques with human induced pluripotent stem cells. It successfully recapitulates features of choriocapillaris and components of Bruchs membranes including RPE induced vascular endothelial fenestration and extracellular matrix formation. We have further demonstrated that HIF-1 induced angiogenesis towards RPE in the tissue and the reduction of the induced angiogenesis with improved barrier functions by bevacizumab treatment. We have also explored the usefulness of this 3D retina tissue model to investigate Zika virus infection and demonstrated viral infection in the tissue and disruption of barrier function. This 3D vascularized ocular tissue model therefore provides extensive opportunities to study underlying mechanisms of relevant diseases and the development of therapeutics.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0261821
发表时间:
2022
期刊:
PloS one
影响因子:
3.7
作者:
[Dorjsuren D, Eastman RT, Song MJ, Yasgar A, Chen Y, Bharti K, Zakharov AV, Jadhav A, Ferrer M, Shi PY, Simeonov A]
通讯作者:
Simeonov A
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent
-
批准号:9205645
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted Omentum tissue to model ovarian cancer metastasis
-
批准号:10683668
-
项目类别:
-
资助金额:$90.89万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted lung cancer models for drug screening
-
批准号:10907367
-
项目类别:
-
资助金额:$226.91万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening
-
批准号:9359917
-
项目类别:
-
资助金额:$15.8万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
-
批准号:9355001
-
项目类别:
-
资助金额:$301.07万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Effectors that target the Fungal-Specific Kinase Drk1 as Novel Antifungal Drug Leads
-
批准号:9205652
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress
-
批准号:9360500
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
-
批准号:9360504
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Small molecule inhibitor screen of MHC II processing pathways using influenza virus A/PR/8/34
-
批准号:9205649
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
High-throughput screens for compounds that reverse cellular toxicity of neurodegenerative disease-associated proteins in yeast models (alpha-synuclein)
-
批准号:9205648
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes
-
批准号:9205632
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
HTS screening for inhibitors of HPV 16 E6/caspase 8 binding
-
批准号:9205653
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of GPR52 antagonists as potential treatments for Huntington Disease
-
批准号:9205646
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of miR-155 expression in Th17 cells
-
批准号:9205636
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening
-
批准号:9205647
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted skin models for drug screening
-
批准号:10683670
-
项目类别:
-
资助金额:$90.89万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
-
批准号:10907368
-
项目类别:
-
资助金额:$10.18万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders
-
批准号:9360493
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC)
-
批准号:9360503
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease
-
批准号:9205664
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
海外基金